The Trump administration is planning an experiment to cover weight loss drugs under Medicare and Medicaid, potentially ...

The Trump administration is considering a five-year pilot program to cover weight-loss drugs under Medicare and Medicaid, the ...

U.S. President Donald Trump listens to remarks during a swearing-in ceremony for Administrator of the Centers for Medicare ...

The Trump administration is planning an experiment to cover weight-loss drugs under Medicare and Medicaid, the Washington ...

Advocates say many consumers might not be aware they are on Medicaid due to the program's frequent name changes.

Several companies, including Oracle and Microsoft, are expected to sign pledges to work on the Trump administration ...

Blockbuster weight loss drugs like Wegovy and Zepbound have surged in popularity, but high prices have left them out of reach ...

Medicare and Medicaid could expand coverage of GLP-1 drugs, such as Ozempic and Wegovy, and pay for patients’ use of the ...

The Medicaid program desperately needs reforms to make sure benefits go to the people who need them most and at a cost that ...

The federal government is expected to start a 5-year-long experiment that will provide some limited coverage of obesity ...

On July 1, about 20,000 Rhode Islanders enrolled in some Medicare Advantage plans from UHC lost their coverage at Brown ...

Proposed experiment would allow states and Medicare drug plans to cover GLP-1 drugs like Ozempic and Wegovy for obesity, The ...